Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carboxymethylcellulose sodium in oropharyngeal dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carboxymethylcellulose sodium in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carmellose sodium 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carmellose sodium in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carmellose sodium 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
False |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carmellose sodium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |